ReLive Biotechnologies
A global regenerative medicine company targeting orthopedics/sports medicine, and plastic & reconstructive surgery .
Enterprise value
$144—216m
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
* | $36.0m | Series A | |
| Total Funding | 000k | ||
